Last 12 months
Inside the activity.
2 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 3, 2026 01:11 UTC |
Knight HeatherDirector
|
GrantCommon Stock | 57.41 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000138 · form4.xml · nonDerivative · entry 1 Knight Heather · CIK 0001967528 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,337.95 F1 · shares: Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur on January 1, 2027, pursuant to an election previously made by the Reporting Person. Read SEC document |
| September 30, 2026 Filed Oct 3, 2026 01:08 UTC |
Jiang WeiDirector
|
GrantCommon Stock | 57.41 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000136 · form4.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,630.16 F1 · shares: Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur automatically upon the Reporting Person's termination of service as a member of the Issuer's Board of Directors. Read SEC document |
| August 06, 2026 Filed Aug 7, 2026 21:20 UTC |
KUEBLER CHRISTOPHER ADirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,626 | $0.00 Strike: $136.43 | $0.00 |
DisclosureSEC source: 0001000697-26-000127 · form4.xml · derivative · entry 3 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,626 shares Expires 2027-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2026 Filed Aug 7, 2026 21:20 UTC |
KUEBLER CHRISTOPHER ADirector
|
SaleCommon Stock | 3,626 | $397.94 | $1,442,930.44 |
DisclosureSEC source: 0001000697-26-000127 · form4.xml · nonDerivative · entry 2 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,808 Read SEC document |
| August 06, 2026 Filed Aug 7, 2026 21:20 UTC |
KUEBLER CHRISTOPHER ADirector
|
Exercise / conversionCommon Stock | 3,626 | $136.43 | $494,695.18 |
DisclosureSEC source: 0001000697-26-000127 · form4.xml · nonDerivative · entry 1 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,434 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:27 UTC |
Knight HeatherDirector
|
GrantCommon Stock | 63.03 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000119 · form4.xml · nonDerivative · entry 1 Knight Heather · CIK 0001967528 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,280.54 F1 · shares: Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur on January 1, 2027, pursuant to an election previously made by the Reporting Person. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:24 UTC |
Jiang WeiDirector
|
GrantCommon Stock | 67.42 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000117 · form4.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,572.75 F1 · shares: Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur automatically upon the Reporting Person's termination of service as a member of the Issuer's Board of Directors. Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 21:25 UTC |
Carpio Robert L IIISVP Waters Analytical Sciences
|
Tax withholdingCommon Stock | 189 | $369.18 | $69,775.02 |
DisclosureSEC source: 0001000697-26-000115 · form4.xml · nonDerivative · entry 1 Carpio Robert L III · CIK 0002027463 · SVP Waters Analytical Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,426 F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:55 UTC |
Chaubal AmolSVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 239 | $352.21 | $84,178.19 |
DisclosureSEC source: 0001000697-26-000113 · form4.xml · nonDerivative · entry 1 Chaubal Amol · CIK 0001773089 · SVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,622.8449 F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units. F2 · balance_after: Includes 65.4519 shares of common stock acquired on March 31, 2026, pursuant to the Waters Corporation Amended and Restated 2009 Employee Stock Purchase Plan, in a transaction that was exempt pursuant to Rule 16b-3(c). Read SEC document |
| April 06, 2026 Filed Apr 7, 2026 20:36 UTC |
Bennett JianqingSVP Waters Adv. Diagnostics
|
Tax withholdingCommon Stock | 302 | $304.09 | $91,835.18 |
DisclosureSEC source: 0001000697-26-000111 · form4.xml · nonDerivative · entry 1 Bennett Jianqing · CIK 0001856691 · SVP Waters Adv. Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,532 F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 21:03 UTC |
Jiang WeiDirector
|
GrantCommon Stock | 64.06 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000109 · form4.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,505.33 F1 · shares: Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur on January 1, 2036, pursuant to an election previously made by the Reporting Person. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 21:00 UTC |
Knight HeatherDirector
|
GrantCommon Stock | 68.44 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000107 · form4.xml · nonDerivative · entry 1 Knight Heather · CIK 0001967528 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,217.51 F1 · shares: Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur on January 1, 2027, pursuant to an election previously made by the Reporting Person. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 20:37 UTC |
Jiang WeiDirector
|
PurchaseCommon Stock | 500 | $289.46 | $144,730.00 |
DisclosureSEC source: 0001000697-26-000105 · form4.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,441.27 Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:21 UTC |
FEARON RICHARD HDirector
|
PurchaseCommon Stock | 1,000 | $306.34 | $306,340.00 |
DisclosureSEC source: 0001000697-26-000103 · form4.xml · nonDerivative · entry 1 FEARON RICHARD H · CIK 0001188586 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,302 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $305.84 to $306.49 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:24 UTC |
Batra UditDirector · President and CEO
|
Tax withholdingCommon Stock | 3,417 | $307.23 | $1,049,804.91 |
DisclosureSEC source: 0001000697-26-000101 · form4.xml · nonDerivative · entry 1 Batra Udit · CIK 0001821498 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,140 F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of previously reported performance stock units. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:22 UTC |
Chaubal AmolSVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 709 | $307.23 | $217,826.07 |
DisclosureSEC source: 0001000697-26-000099 · form4.xml · nonDerivative · entry 1 Chaubal Amol · CIK 0001773089 · SVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,796.393 F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of previously reported performance stock units. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:19 UTC |
Bennett JianqingSVP Waters Adv. Diagnostics
|
Tax withholdingCommon Stock | 410 | $307.23 | $125,964.30 |
DisclosureSEC source: 0001000697-26-000097 · form4.xml · nonDerivative · entry 1 Bennett Jianqing · CIK 0001856691 · SVP Waters Adv. Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,834 F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of previously reported performance stock units. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:33 UTC |
Carpio Robert L IIISVP Waters Analytical Sciences
|
GrantStock Option (Right to Buy) · Derivative | 4,884 | $0.00 Strike: $319.44 | $0.00 |
DisclosureSEC source: 0001000697-26-000095 · form4.xml · derivative · entry 2 Carpio Robert L III · CIK 0002027463 · SVP Waters Analytical Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,884 Underlying: Common Stock · 4,884 shares Expires 2036-02-25 F2 · derivative.exercise_date: The shares of common stock underlying this stock option will vest and become exercisable in four equal annual installments, with the first such installment vesting and becoming exercisable on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:33 UTC |
Carpio Robert L IIISVP Waters Analytical Sciences
|
GrantCommon Stock | 997 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000095 · form4.xml · nonDerivative · entry 1 Carpio Robert L III · CIK 0002027463 · SVP Waters Analytical Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,615 F1 · shares: Represents restricted stock units ("RSUs"), which will vest in four equal annual installments, with the first such installment vesting on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date. The RSUs are convertible into shares of the Issuer's common stock on a one-to-one basis upon vesting and settlement. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:32 UTC |
Bennett JianqingSVP Waters Adv. Diagnostics
|
GrantStock Option (Right to Buy) · Derivative | 4,826 | $0.00 Strike: $319.44 | $0.00 |
DisclosureSEC source: 0001000697-26-000093 · form4.xml · derivative · entry 2 Bennett Jianqing · CIK 0001856691 · SVP Waters Adv. Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,826 Underlying: Common Stock · 4,826 shares Expires 2036-02-25 F2 · derivative.exercise_date: The shares of common stock underlying this stock option will vest and become exercisable in four equal annual installments, with the first such installment vesting and becoming exercisable on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:32 UTC |
Bennett JianqingSVP Waters Adv. Diagnostics
|
GrantCommon Stock | 986 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000093 · form4.xml · nonDerivative · entry 1 Bennett Jianqing · CIK 0001856691 · SVP Waters Adv. Diagnostics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,244 F1 · shares: Represents restricted stock units ("RSUs"), which will vest in four equal annual installments, with the first such installment vesting on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date. The RSUs are convertible into shares of the Issuer's common stock on a one-to-one basis upon vesting and settlement. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:31 UTC |
Chaubal AmolSVP & Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 7,125 | $0.00 Strike: $319.44 | $0.00 |
DisclosureSEC source: 0001000697-26-000091 · form4.xml · derivative · entry 2 Chaubal Amol · CIK 0001773089 · SVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,125 Underlying: Common Stock · 7,125 shares Expires 2036-02-25 F2 · derivative.exercise_date: The shares of common stock underlying this stock option will vest and become exercisable in four equal annual installments, with the first such installment vesting and becoming exercisable on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:31 UTC |
Chaubal AmolSVP & Chief Financial Officer
|
GrantCommon Stock | 1,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000091 · form4.xml · nonDerivative · entry 1 Chaubal Amol · CIK 0001773089 · SVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,505.393 F1 · shares: Represents restricted stock units ("RSUs"), which will vest in four equal annual installments, with the first such installment vesting on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date. The RSUs are convertible into shares of the Issuer's common stock on a one-to-one basis upon vesting and settlement. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:29 UTC |
Batra UditDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 25,283 | $0.00 Strike: $319.44 | $0.00 |
DisclosureSEC source: 0001000697-26-000089 · form4.xml · derivative · entry 2 Batra Udit · CIK 0001821498 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,283 Underlying: Common Stock · 25,283 shares Expires 2036-02-25 F2 · derivative.exercise_date: The shares of common stock underlying this stock option will vest and become exercisable in four equal annual installments, with the first such installment vesting and becoming exercisable on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:29 UTC |
Batra UditDirector · President and CEO
|
GrantCommon Stock | 5,165 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000089 · form4.xml · nonDerivative · entry 1 Batra Udit · CIK 0001821498 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,557 F1 · shares: Represents restricted stock units ("RSUs"), which will vest in four equal annual installments, with the first such installment vesting on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date. The RSUs are convertible into shares of the Issuer's common stock on a one-to-one basis upon vesting and settlement. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:23 UTC |
KUEBLER CHRISTOPHER ADirector
|
GrantStock Option (Right to Buy) · Derivative | 57 | $0.00 Strike: $319.44 | $0.00 |
DisclosureSEC source: 0001000697-26-000085 · form4.xml · derivative · entry 2 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57 Underlying: Common Stock · 57 shares Expires 2036-02-25 F2 · shares: All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:23 UTC |
KUEBLER CHRISTOPHER ADirector
|
GrantCommon Stock | 23 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000085 · form4.xml · nonDerivative · entry 1 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,808 F1 · shares: Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:25 UTC |
Vergnano MarkDirector
|
GrantStock Option (Right to Buy) · Derivative | 57 | $0.00 Strike: $319.44 | $0.00 |
DisclosureSEC source: 0001000697-26-000087 · form4.xml · derivative · entry 2 Vergnano Mark · CIK 0001474107 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57 Underlying: Common Stock · 57 shares Expires 2036-02-25 F2 · shares: All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:25 UTC |
Vergnano MarkDirector
|
GrantCommon Stock | 23 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000087 · form4.xml · nonDerivative · entry 1 Vergnano Mark · CIK 0001474107 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,540 F1 · shares: Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:22 UTC |
Knight HeatherDirector
|
GrantStock Option (Right to Buy) · Derivative | 57 | $0.00 Strike: $319.44 | $0.00 |
DisclosureSEC source: 0001000697-26-000083 · form4.xml · derivative · entry 2 Knight Heather · CIK 0001967528 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57 Underlying: Common Stock · 57 shares Expires 2036-02-25 F2 · shares: All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:22 UTC |
Knight HeatherDirector
|
GrantCommon Stock | 23 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000083 · form4.xml · nonDerivative · entry 1 Knight Heather · CIK 0001967528 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,149.07 F1 · shares: Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:21 UTC |
Jiang WeiDirector
|
GrantStock Option (Right to Buy) · Derivative | 57 | $0.00 Strike: $319.44 | $0.00 |
DisclosureSEC source: 0001000697-26-000081 · form4.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57 Underlying: Common Stock · 57 shares Expires 2036-02-25 F2 · shares: All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:21 UTC |
Jiang WeiDirector
|
GrantCommon Stock | 23 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000081 · form4.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,941.27 F1 · shares: Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:19 UTC |
Huang Pearl SDirector
|
GrantStock Option (Right to Buy) · Derivative | 57 | $0.00 Strike: $319.44 | $0.00 |
DisclosureSEC source: 0001000697-26-000079 · form4.xml · derivative · entry 2 Huang Pearl S · CIK 0001837486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57 Underlying: Common Stock · 57 shares Expires 2036-02-25 F2 · shares: All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:19 UTC |
Huang Pearl SDirector
|
GrantCommon Stock | 23 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000079 · form4.xml · nonDerivative · entry 1 Huang Pearl S · CIK 0001837486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,276.3 F1 · shares: Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:18 UTC |
Fraser ClaireDirector
|
GrantStock Option (Right to Buy) · Derivative | 877 | $0.00 Strike: $319.44 | $0.00 |
DisclosureSEC source: 0001000697-26-000077 · form4.xml · derivative · entry 2 Fraser Claire · CIK 0001382031 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 877 Underlying: Common Stock · 877 shares Expires 2036-02-25 F2 · shares: All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:18 UTC |
Fraser ClaireDirector
|
GrantCommon Stock | 358 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000077 · form4.xml · nonDerivative · entry 1 Fraser Claire · CIK 0001382031 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 489 F1 · shares: Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:16 UTC |
FEARON RICHARD HDirector
|
GrantStock Option (Right to Buy) · Derivative | 57 | $0.00 Strike: $319.44 | $0.00 |
DisclosureSEC source: 0001000697-26-000075 · form4.xml · derivative · entry 2 FEARON RICHARD H · CIK 0001188586 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57 Underlying: Common Stock · 57 shares Expires 2036-02-25 F2 · shares: All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:16 UTC |
FEARON RICHARD HDirector
|
GrantCommon Stock | 23 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000075 · form4.xml · nonDerivative · entry 1 FEARON RICHARD H · CIK 0001188586 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,302 F1 · shares: Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:13 UTC |
Brennan Daniel J.Director
|
GrantStock Option (Right to Buy) · Derivative | 57 | $0.00 Strike: $319.44 | $0.00 |
DisclosureSEC source: 0001000697-26-000073 · form4.xml · derivative · entry 2 Brennan Daniel J. · CIK 0001595612 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57 Underlying: Common Stock · 57 shares Expires 2036-02-25 F2 · shares: All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:13 UTC |
Brennan Daniel J.Director
|
GrantCommon Stock | 23 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000073 · form4.xml · nonDerivative · entry 1 Brennan Daniel J. · CIK 0001595612 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,355 F1 · shares: Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:12 UTC |
BADDOUR LINDADirector
|
GrantStock Option (Right to Buy) · Derivative | 57 | $0.00 Strike: $319.44 | $0.00 |
DisclosureSEC source: 0001000697-26-000071 · form4.xml · derivative · entry 2 BADDOUR LINDA · CIK 0001181151 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57 Underlying: Common Stock · 57 shares Expires 2036-02-25 F2 · shares: All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:12 UTC |
BADDOUR LINDADirector
|
GrantCommon Stock | 23 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000071 · form4.xml · nonDerivative · entry 1 BADDOUR LINDA · CIK 0001181151 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,899 F1 · shares: Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:09 UTC |
Ornskov FlemmingDirector
|
GrantStock Option (Right to Buy) · Derivative | 57 | $0.00 Strike: $319.44 | $0.00 |
DisclosureSEC source: 0001000697-26-000069 · form4.xml · derivative · entry 2 Ornskov Flemming · CIK 0001709473 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57 Underlying: Common Stock · 57 shares Expires 2036-02-25 F2 · shares: All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:09 UTC |
Ornskov FlemmingDirector
|
GrantCommon Stock | 336 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000069 · form4.xml · nonDerivative · entry 1 Ornskov Flemming · CIK 0001709473 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,271 F1 · shares: Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027. Read SEC document |
| February 05, 2026 Filed Feb 7, 2026 00:34 UTC |
Carpio Robert L IIISVP, Waters Division
|
Tax withholdingCommon Stock | 38 | $376.89 | $14,321.82 |
DisclosureSEC source: 0001000697-26-000048 · form4.xml · nonDerivative · entry 1 Carpio Robert L III · CIK 0002027463 · SVP, Waters Division 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,618 F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units. Read SEC document |
| February 05, 2026 Filed Feb 7, 2026 00:33 UTC |
Bennett JianqingSVP TA Instruments Division
|
Tax withholdingCommon Stock | 43 | $376.89 | $16,206.27 |
DisclosureSEC source: 0001000697-26-000046 · form4.xml · nonDerivative · entry 2 Bennett Jianqing · CIK 0001856691 · SVP TA Instruments Division 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,258 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units. Read SEC document |
| February 05, 2026 Filed Feb 7, 2026 00:32 UTC |
Chaubal AmolSVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 58 | $376.89 | $21,859.62 |
DisclosureSEC source: 0001000697-26-000044 · form4.xml · nonDerivative · entry 2 Chaubal Amol · CIK 0001773089 · SVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,050.393 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units. Read SEC document |
| February 05, 2026 Filed Feb 7, 2026 00:29 UTC |
Batra UditDirector · President and CEO
|
Tax withholdingCommon Stock | 218 | $376.89 | $82,162.02 |
DisclosureSEC source: 0001000697-26-000042 · form4.xml · nonDerivative · entry 2 Batra Udit · CIK 0001821498 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,392 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units. Read SEC document |
| February 04, 2026 Filed Feb 7, 2026 00:33 UTC |
Bennett JianqingSVP TA Instruments Division
|
GrantCommon Stock | 1,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000046 · form4.xml · nonDerivative · entry 1 Bennett Jianqing · CIK 0001856691 · SVP TA Instruments Division 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,301 F1 · shares: Represents performance-based restricted stock units ("PSUs") originally granted on February 8, 2023, subject to pre-determined service and performance-based vesting requirements. The level of achievement of the performance-based vesting requirement for the PSUs was certified by the Issuer's Compensation Committee on February 4, 2026, and the PSUs will vest in full upon satisfaction of the service-based vesting requirement on March 1, 2026. The PSUs are convertible into shares of the Issuer's Common Stock on a one-to-one basis upon vesting and settlement. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.